Abstract:Aim To explore the in vitro and in vivo angiogenic capacity and phenotypic properties about different clonal endothelial progenitor cell populations derived from human peripheral circulating blood. Methods Mononuclear cells were isolated by density-gradient centrifugation and incubated onto fibronectin-coated dishes in endothelial medium in the presence of vascular endothelial growth factor.The number of early clones was counted at 7 days and cells from another aliquot were cultivated continually until the late clones generated.Flow cytometry analysis was used to evaluate cells surface antigen expression and von willebrand factor(vWF),the endothelial cells marker was detected by indirect fluorescence staining.The capacities of in vitro and in vivo vascular genesis were assessed by plating cells onto collagen gels and implanting the cellularized gel into nude mice. Results Early clones failed to form second clone and were devoid of the capacity of in vitro and in vivo vascular genesis.Furthermore,cells derived from the early clones expressed mainly CD14 and CD45.In contrast to early clones,the late clones emerged until 21 to 28 days after cultivation and exhibited typically endothelial cells properties.Remarkably,cells originated from late clones had the ability to form second endothelial clones after replanted and generated tube-like structures when seeded onto collagen gels or transplanted into nude mice.In addition to the clearly morphological and functional differences,cells derived from late clones expressed obviously increased CD146(P<0.01) and reduced CD45 and CD14(P<0.001). Conclusions Under endothelial cultivating conditions,human peripheral blood mononuclear cells can generate early and late clones.Only cells originated from late clones exhibit double phenotypes of stem/progenitor and endothelial cells with the capacity of in vitro and in vivo vasculargenesis.

Angiogenesis and Functional Vessel Formation Induced by Interstitial Flow and Vascular Endothelial Growth Factor Using a Microfluidic Chip

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

In Vitro and in Vivo Angiogenic Capacity Analysis on Different Clonal Endothelial Progenitor Cell Populations Derived from Human Circulating Blood

On-chip-angiogenesis Based on a High-Throughput Biomimetic Three-Dimensional Cell Spheroid Culture System.

A Novel in Vitro Angiogenesis Model Based on a Microfluidic Device

Microfluidic Model to Mimic Initial Event of Neovascularization

A Perforated Microhole-Based Microfluidic Device for Improving Sprouting Angiogenesis in Vitro

Human Ocular Angiogenesis‐Inspired Vascular Models on an Injection‐Molded Microfluidic Chip

Biomimetic Tumor-Induced Angiogenesis and Anti-Angiogenic Therapy in A Microfluidic Model

Integrated Effects of Matrix Mechanics and Vascular Endothelial Growth Factor (VEGF) on Capillary Sprouting

Quantitative Phase Imaging Characterization of Tumor-Associated Blood Vessel Formation on a Chip

Functional Angiogenesis Requires Microenvironmental Cues Balancing Endothelial Cell Migration and Proliferation.

Long-term cultured microvascular networks on chip for tumor vascularization research and drug testing

Microfluidic Chips for the Endothelial Biomechanics and Mechanobiology of the Vascular System

Angiogenic Synergistic Effect of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in an in Vitro Quantitative Microcarrier-Based Three-Dimensional Fibrin Angiogenesis System

Endothelialized microrods for minimally invasive <i>in situ</i> neovascularization.

Multilayered Modular Microfluidic Platform for 3D Vascularized Organ-on-a-chip Application

Different Angiogenesis Modes and Endothelial Responses in Implanted Porous Biomaterials

Enrichment and detection of VEGF165 in blood samples on a microfluidic chip integrated with multifunctional units

A microfluidic platform integrating functional vascularized organoids-on-chip

An Open-Space Microfluidic Chip with Fluid Walls for Online Detection of VEGF Via Rolling Circle Amplification